FORMULATION, DEVELOPMENT AND OPTIMIZATION OF NOVEL VESICLE SYSTEM CONTAINING THIOCOLCHICOSIDE BY DESIGN OF EXPERIMENT APPROACH

This study aimed to develop and optimize a novel vesicular drug delivery system glycerosomes for the effective encapsulation and controlled release of Thiocolchicoside, a poorly water-soluble muscle relaxant.

Publication Details

Journal: Zenodo (CERN European Organization for Nuclear Research)
Published: 2025-08-13
DOI: https://doi.org/10.5281/zenodo.16847481
Primary Topic: Lipid Membrane Structure and Behavior
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

FORMULATION, DEVELOPMENT AND OPTIMIZATION OF NOVEL VESICLE SYSTEM CONTAINING THIOCOLCHICOSIDE BY DESIGN OF EXPERIMENT APPROACH

Aug 13, 2025

Zenodo (CERN European Organization for Nuclear Research)

Lipid Membrane Structure and Behavior

article

FORMULATION, DEVELOPMENT AND OPTIMIZATION OF NOVEL VESICLE SYSTEM CONTAINING THIOCOLCHICOSIDE BY DESIGN OF EXPERIMENT APPROACH

August 13, 2025article en

Abstract

Zenodo (CERN European Organization for Nuclear Research)

Good health and well-being

Openalex Percentile: Top 60%

Lipid Membrane Structure and Behavior

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

FORMULATION, DEVELOPMENT AND OPTIMIZATION OF NOVEL VESICLE SYSTEM CONTAINING THIOCOLCHICOSIDE BY DESIGN OF EXPERIMENT APPROACH · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS